Literature DB >> 2679269

Use and misuse of metered-dose inhalers by patients with chronic lung disease. A controlled, randomized trial of two instruction methods.

P De Blaquiere1, D B Christensen, W B Carter, T R Martin.   

Abstract

Metered-dose inhalers are often used incorrectly by patients with chronic airflow obstruction, and there is a lack of controlled studies designed to evaluate methods to teach the correct use of these devices. Therefore, we screened 100 consecutive stable outpatients for correct or incorrect inhaler use and then conducted a randomized trial of two methods to teach correct use. Patients were classified as correct or incorrect users with a modified metered-dose inhaler containing a thermistor that detected inspiration, inhaler activation, and the duration of breath-holding. Patients were classified as incorrect users if they failed to: (1) activate the inhaler once during inspiration, and/or (2) hold their breath at the end of inspiration. There were 38 correct users and 62 incorrect users. Incorrect users were randomized to one of two teaching protocols: (1) standardized verbal instruction alone, or (2) standardized verbal instruction plus an automatic visual signal during inspiration. Incorrect users were restudied 6 to 10 wk later to reassess technique. Both treatment protocols were equally effective in converting incorrect user. However, the verbal instruction alone required significantly less time than the instruction with the mechanical aid. For all subjects, the proportion using correct technique declined over time, particularly for incorrect users. We also examined a series of patient characteristics, obtained by questionnaire and spirometry, to determine whether they could be used in the clinical setting to identify incorrect users. By discriminant analysis, a group of four variables predicted correct metered-dose inhaler use: bronchodilator responsiveness, a history of additional about proper technique, verbal knowledge of the correct inhaler maneuvers, and the patient's perception of whether it is important to use an inhaler.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2679269     DOI: 10.1164/ajrccm/140.4.910

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  16 in total

1.  Results of a programme to improve house staff use of metered dose inhalers and spacers.

Authors:  M Lee-Wong; P H Mayo
Journal:  Postgrad Med J       Date:  2003-04       Impact factor: 2.401

2.  Efficient inhaler devices.

Authors:  D K Cragg
Journal:  Br J Gen Pract       Date:  1996-03       Impact factor: 5.386

3.  North of England evidence based guidelines development project: summary version of evidence based guideline for the primary care management in adults.

Authors: 
Journal:  BMJ       Date:  1996-03-23

4.  Metered-dose inhaler technique among healthcare providers practising in Oman.

Authors:  Sawsan A Baddar; Omar A Al-Rawas; Kassim A Al-Riyami; Elizabeth A Worthing; Yolande I Hanssens; Aqeela M Taqi; Bazdawi M S Al-Riyami
Journal:  J Sci Res Med Sci       Date:  2001-04

Review 5.  What can be done to impact respiratory inhaler misuse: exploring the problem, reasons, and solutions.

Authors:  Anna Volerman; Delesha Carpenter; Valerie Press
Journal:  Expert Rev Respir Med       Date:  2020-04-28       Impact factor: 3.772

6.  Evaluation of the effectiveness of four different inhalers in patients with chronic obstructive pulmonary disease.

Authors:  J van der Palen; J J Klein; A H Kerkhoff; C L van Herwaarden
Journal:  Thorax       Date:  1995-11       Impact factor: 9.139

7.  Kinetics of action of salbutamol inhaled from a metered dose inhaler (MDI) and a "Diskhaler".

Authors:  M Mathieu; M Goldman; N Lellouche; R Sartene
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

Review 8.  Device errors in asthma and COPD: systematic literature review and meta-analysis.

Authors:  Henry Chrystyn; Job van der Palen; Raj Sharma; Neil Barnes; Bruno Delafont; Anadi Mahajan; Mike Thomas
Journal:  NPJ Prim Care Respir Med       Date:  2017-04-03       Impact factor: 2.871

9.  The challenge of delivering therapeutic aerosols to asthma patients.

Authors:  Federico Lavorini
Journal:  ISRN Allergy       Date:  2013-08-05

10.  Single-inhaler fluticasone furoate/umeclidinium/vilanterol versus fluticasone furoate/vilanterol plus umeclidinium using two inhalers for chronic obstructive pulmonary disease: a randomized non-inferiority study.

Authors:  Peter R Bremner; Ruby Birk; Noushin Brealey; Afisi S Ismaila; Chang-Qing Zhu; David A Lipson
Journal:  Respir Res       Date:  2018-01-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.